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Mutations in the transcription factor Pdx1 cause
maturity-onset diabetes of the young 4 (MODY4).
Islet transduction with dominant-negative Pdx1
(RIPDN79PDX1) impairs mitochondrial metabolism
and glucose-stimulated insulin secretion (GSIS).
Transcript profiling revealed suppression of nuclear-
encoded mitochondrial factor A (TFAM). Herein, we
show that Pdx1 suppression in adult mice reduces
islet TFAM expression coinciding with hypergly-
cemia. We define TFAM as a direct target of Pdx1
both in rat INS1 cells and human islets. Adenoviral
overexpression of TFAM along with RIPDN79PDX1
in isolated rat islets rescued mitochondrial DNA
(mtDNA) copy number and restored respiratory chain
activity as well as glucose-induced ATP synthesis
and insulin secretion. CGP37157, which blocks the
mitochondrial Na+/Ca2+ exchanger, restored ATP
generation and GSIS in RIPDN79PDX1 islets, thereby
bypassing the transcriptional defect. Thus, the
genetic control by the b cell-specific factor Pdx1 of
the ubiquitous gene TFAM maintains b cell mtDNA
vital for ATP production and normal GSIS.
INTRODUCTION
Mitochondria are the site of cellular energy provision and control
not only vital functions but also specialized processes such as
insulin secretion in the pancreatic b cells (Maechler and Woll-
heim, 2001; Wiederkehr and Wollheim, 2008). Normal glucose
homeostasis depends on the efficient adaptation of insulin
secretion rates to the actual blood glucose concentration. The
b cell is poised to funnel glucose-derived metabolites to the
mitochondria through its unique gene-expression profile, permit-
ting the generation of ATP and other factors coupling metabo-110 Cell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Inlism to insulin exocytosis (Gauthier et al., 2008; Jensen et al.,
2008; Wiederkehr and Wollheim, 2006). The end product of
glycolysis in the b cell is pyruvate, which is transferred to the
mitochondria, leading to the generation of NADH and FADH2
(Ishihara et al., 1999). Oxidation of these reducing equivalents
drives proton pumping of respiratory chain complexes, resulting
in hyperpolarization of the electrical potential and mitochondrial
matrix alkalinization (Wiederkehr et al., 2009). These changes
accelerate mitochondrial ATP synthesis, resulting in the closure
of ATP-sensitive K+ channels at the plasma membrane, causing
depolarization and calcium influx (Hiriart and Aguilar-Bryan,
2008). The rise in cytosolic Ca2+, apart from triggering insulin
exocytosis, is relayed to the mitochondrial matrix, where the
activity of dehydrogenases is stimulated, thereby reinforcing
the generation of metabolic coupling factors (Wiederkehr and
Wollheim, 2008).
The respiratory chain function is critically dependent on both
nuclear and mitochondrial gene transcription. In fact, 13 of the
many polypeptide subunits of complex I, III, IV, and V are
encoded by the mtDNA, whereas subunits of complex II (succi-
nate dehydrogenase) are nuclear encoded. Mutations or dele-
tions in the mitochondrial genome lead to a rare form of diabetes,
maternally inherited diabetes (MID) (Maassen et al., 2005), illus-
trating the importance of mitochondria in b cell function. Stability
and transcriptional activity of mtDNA is predominantly controlled
by a nuclear-encoded factor, mitochondrial transcription factor
A (TFAM) (Falkenberg et al., 2007; Scarpulla, 2008). The vital
function of TFAM is illustrated by the lethal phenotype of the
global TFAM ablation in the mouse. Organ-targeted depletion
of TFAM has substantiated the importance of mitochondrial
metabolism in various cell types, including cardiomyocytes
and b cells (Larsson and Rustin, 2001; Silva et al., 2000). Further-
more, mitochondrial dysfunction accelerates biological aging,
and a polymorphism in the tfam gene has been associated
with familial Alzheimer’s disease (Belin et al., 2007). Conversely,
mice overexpressing TFAM are protected from age-dependent
impairment of brain performance by preserving mitochondrial
function in microglia (Hayashi et al., 2008).c.
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TFAM and Defective Insulin SecretionThe pancreatic homeodomain transcription factor Pdx1
(pancreatic duodenal homeobox 1) is considered a b cell master
gene, important for its embryonic development and differenti-
ated function (Oliver-Krasinski and Stoffers, 2008; Servitja and
Ferrer, 2004). Homozygous null mutations in the pdx1 gene result
in pancreas agenesis, whereas heterozygosity is associated with
maturity-onset diabetes of the young 4 (MODY4) (Oliver-Krasin-
ski and Stoffers, 2008). A recent genome-wide linkage and
admixture mapping of type 2 diabetes includes Pdx1 as a
candidate gene in African American subjects (Elbein et al.,
2009). Pdx1+/ mutant mice display impaired insulin secretion
and late-onset b cell apoptosis (Brissova et al., 2002; Johnson
et al., 2003). Both defects were recapitulated using an in vitro
rat islet model expressing a dominant-negative variant of Pdx1
lacking the main transactivation domain (DN79PDX1) (Gauthier
et al., 2004). The blunted glucose-stimulated insulin secretion
(GSIS) was linked to impaired mitochondrial function, a conse-
quence of decreased transcription of mtDNA-encoded enzyme
subunits of the respiratory chain. Remarkably, TFAM transcript
levels were markedly suppressed, suggesting that Pdx1 may
regulate transcription of mtDNA-encoded genes via regulation
of TFAM (Gauthier et al., 2004). Here, we tested whether TFAM
expression and/or normalization of mitochondrial calcium
signals can restore mitochondrial function and metabolism-
secretion coupling in Pdx1 loss-of-function islets.
RESULTS
TFAM Expression Is Regulated by Pdx1 In Vivo
To investigate whether TFAM is a target of Pdx1, studies were
performed in a transgenic mouse model that allows the condi-
tional doxycycline (DOX)-dependent suppression of Pdx1 in adult
animals (Holland et al., 2002, 2005). DOX was administered to
6-month-old male mice for 14 consecutive days. This resulted in
the expected massive reduction of Pdx1 expression (decreased
by 90%) and marked increase in blood glucose secondary to
b cell dysfunction (Figure 1). The transcript level of the nuclear-
encoded gene TFAM was also reduced by 55%. As a conse-
quence, there was a suppression of ND1, a mitochondrial DNA
(mtDNA)-encoded subunit of respiratory chain complex I NADH
DH (Figure 1B). These results recapitulate in an in vivo model
our earlier observations in rat islets transduced with a dominant-
negative variant of Pdx1 (Gauthier et al., 2004). TFAM transcript
levels were also assessed in islets isolated from PDX1+/ mice
(Brissova et al., 2002). Surprisingly, Pdx1 mRNA levels were
only marginally decreased, by 23% ± 5%, relative to control litter-
mates, with a minute nonsignificant decrease in TFAM mRNA
(10% ± 4%, n = 5). Thus, it appears that Pdx1 expression levels
in this model of heterozygous mice (Brissova et al., 2002) are
higher than the expected 50%, resulting in only minor changes
in TFAM transcript.
Pdx1 Controls TFAM Transcriptional Activity
As our previous in vitro studies were performed with rat islets, we
next performed an in silico scan of the rat tfam gene promoter for
putative Pdx1 binding sites. A single homeobox consensus core
sequence was identified at position 462 with respect to the
transcriptional start site (Figure 2A). Using an INS-1 cell line
permitting DOX-inducible overexpression of Pdx1 (Wang et al.,C2001), we performed electrophoretic mobility shift assays
(EMSAs). Nuclear extracts from cells induced with DOX revealed
a retarded complex with the known InsFAR target sequence of
the insulin gene promoter (Figure 2B, lane 2). Specificity of the
complex was demonstrated using a Pdx1 antibody, which
inhibited the protein-DNA interaction (Figure 2B, lane 3). Under
noninduced conditions, a band was visible using the putative
Pdx1 binding domain of the TFAM promoter (Figure 2B, lane 4).
This complex was more abundant when Pdx1 was overex-
pressed (Figure 2B, lane 5). This band disappeared in the pres-
ence of anti-Pdx1 serum (Figure 2B, lane 6). To substantiate
the binding of Pdx1 to the tfam gene promoter in intact cells,
chromatin immunoprecipitation (ChIP) experiments were per-
formed in the Pdx1-overexpressing INS-1 cells. As Pdx1 binds
to the gene promoters of insulin and iapp (islet amyloid polypep-
tide), a 5-fold enrichment was observed when the promoters
were amplified from the immunoprecipitates. Enrichment was
also observed for the tfam gene promoter, while MyoD remained
unaltered (Figure 2C). The impact of Pdx1 on tfam transcription
was assessed in heterologous BHK-21 cells. Transient cotrans-
fections with increasing amounts of a Pdx1 expression plasmid
Figure 1. Reduced TFAM Expression and Hyperglycemia Ensue
Subsequent to Doxycycline-Mediated Repression of Pdx1 In Vivo
(A) Pdx1tTA/tTA; TgPdx1 transgenic mice bearing a conditionally DOX-repressed
pdx1 transgene were given a single i.p. injection of DOX (100 mg/kg in final
volume of 250 ml of water) followed by 14 days of treatment in the drinking
water. Fasting blood glucose was measured daily using a Precision Xceed
apparatus.
(B) Pdx1, TFAM, and NADDH ND1 mRNA levels were then determined by
quantitative RT-PCR and normalized to the housekeeping gene, cyclophilin.
Values are derived from three independent pairs of animals and are presented
as fold repression as compared to control non-DOX-treated mice. **p < 0.01.ell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Inc. 111
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TFAM and Defective Insulin SecretionFigure 2. Pdx1 Interacts and Transactivates the
Rat tfam Gene Promoter
(A) Schematic representation of the proximal rat tfam gene
promoter (462 to +1) and three of its interacting regula-
tors (Sp1, NRF1, and NRF2) that are essential for transcrip-
tion of the gene. The putative Pdx1 binding site is shown in
the box below. Bold nucleotides represent the core recog-
nition sequence of Pdx1.
(B) Nonradioactive EMSA using either a biotin-labeled
INSFLAT element or the putative Pdx1 binding site of the
TFAM promoter. Six micrograms of nuclear extracts iso-
lated from a clonal INS-1 cell line that conditionally
expresses Pdx1 in the presence of DOX (rab-Pdx1-21)
(Wang et al., 2001) were incubated with labeled oligonu-
cleotides. Specificity of the Pdx1 complexes was
confirmed by the addition of anti-Pdx1 serum in lanes 3
and 6.
(C) ChIP assay shown as histograms representing the rela-
tive binding of the Pdx1 protein to the TFAM promoter in
rab-Pdx1-21 treated with DOX. After crosslinking, immu-
noprecipitations were performed with anti-Pdx1 as indi-
cated in the Experimental Procedures. A nonspecific IgG
immunoprecipitation was also performed as negative
control. Binding capacity to the MyoD (negative control),
Ins2, and IAPP (positive controls) as well as to the TFAM
promoter was analyzed by real-time RT-PCR. Binding
intensity data were normalized to MyoD (nonspecific
binding) and are presented as the mean ± SEM for at least
three independent experiments.
(D) Effect of Pdx1 on the transcriptional activation of
the tfam gene promoter. Cotransfection studies using
BHK-21 cells were performed with a TFAM promoter/
luciferase reporter construct and increasing amounts of
a Pdx1 expression vector (0.125, 0.25, 0.5, and 1 mg). The
pSV-b-galactosidase control vector was used as internal
control to normalize for transfection efficiency (approxi-
mately 15%). Data are presented as fold induction of basal
luciferase activity and expressed as the mean ± SEM of
4–5 independent experiments. ** denotes p < 0.01.evoked a dose-dependent enhancement of a TFAM promoter/
luciferase construct (Figure 2D).
Next, we verified Pdx1 binding to the tfam gene promoter in
human islets. In silico, nine putative binding sites were identified
in the human TFAM promoter (Figure 3A). Of these, TFAM2, 4, 6,
and 8 exhibited bona fide interactions with Pdx1, as demon-
strated by ChIP experiments (Figure 3B). Taken together, these
results clearly show that Pdx1 binds to the TFAM promoter
and activates its transcription.
TFAM Rescues Mitochondrial Gene Expression
and Copy Number
To evaluate whether TFAM is a key factor linking Pdx1 to mito-
chondrial function as suggested previously (Gauthier et al.,
2004), rat islets were infected with a TFAM-encoding adenovirus
(AdrTFAM). Increasing concentrations of the virus resulted in
graded overexpression of TFAM mRNA (Figure 4A). The overex-
pressed TFAM protein was correctly targeted to the mitochon-
dria and was absent from the cytosolic fraction (Figure 4B).
Further experiments were conducted with the lower viral
concentration. Such transduced islets were used to monitor
the expression of the mtDNA-encoded respiratory chain
complex I subunit ND1. In islets infected with AdRIPDN79PDX1,
the ND1 transcript was decreased by 60% (Figure 4C) (Gauthier112 Cell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Inet al., 2004). Under these experimental conditions, we have
shown that DN79PDX1 protein levels are 10-fold higher than
those of endogenous Pdx1 (Gauthier et al., 2004). TFAM
increased ND1 mRNA, partially correcting the defect of islets
expressing DN79PDX1, but failed to augment ND1 expression
in control islets (Figure 4C). In contrast, TFAM overexpression
did not attenuate the increase of the nuclear-encoded succinate
dehydrogenase transcript, which is upregulated by DN79PDX1
(Gauthier et al., 2004). Apart from regulating mtDNA transcrip-
tion, TFAM is known to control copy number of the mitochondrial
genome (Ekstrand et al., 2004; Scarpulla, 2008). Consistent with
these findings, islets expressing DN79PDX1 exhibited a 35%
decrease in ND1 mtDNA, while the nuclear gene succinate dehy-
drogenase remained constant. TFAM expression protected
against DN79PDX1-mediated lowering of ND1 DNA, confirming
the role of TFAM in stabilizing mtDNA (Figure 5).
TFAM Restores Metabolism-Secretion Coupling
Glucose-induced ATP generation in the b cell is a measure of
respiratory chain activity (Wiederkehr and Wollheim, 2008).
ATP was monitored in living cells using cytosolic luciferase as
previously described (Gauthier et al., 2004). Islets expressing
DN79PDX1 displayed a markedly reduced ATP response to
16.5 mM glucose relative to control islets (75% reduction)c.
Cell Metabolism
TFAM and Defective Insulin Secretion(Figure 6A). Overexpression of TFAM did not change glucose-
evoked ATP generation under control conditions, but restored
ATP responses in islets transduced with AdRIPDN79PDX1
(Figure 6A). TFAM was able to completely normalize defective
GSIS of the DN79PDX1-expressing islets (Figure 6B). Of note,
viral infection over 48 hr did not alter islet insulin content (data
not shown). These results suggest a link between mitochondrial
metabolism and Pdx1 action, most probably mediated through
TFAM expression.
CGP37157 Rescues Signaling and Insulin Secretion
Impaired ATP synthesis and GSIS are associated with lowered
cytosolic and mitochondrial calcium responses. Mitochondrial
calcium serves as a potentiating signal in mitochondrial energy
metabolism (Wiederkehr and Wollheim, 2008). Lowered mito-
chondrial calcium could therefore contribute to the observed
defect in metabolism secretion coupling of islets with impaired
Pdx1 function. Indeed, expression of DN79PDX1 in islets lowered
the mitochondrial calcium response to glucose (Figures 7A and
Figure 3. Pdx1 Binds to the Human tfam Gene Promoter
(A) Putative Pdx1 binding sites identified in the 50-flanking region of the human
tfam gene. Bold nucleotides correspond to the core recognition sequence of
Pdx1. Location of each sequence relative to the transcriptional initiation site
is provided in brackets.
(B) Histograms representing the relative binding of the Pdx1 protein to the
TFAM promoter in human islets. After crosslinking, immunoprecipitations
were performed with anti-Pdx1 as indicated in the Experimental Procedures.
Binding capacity to the Actin B (ActB, negative control), insulin (Ins, positive
control), and the TFAM (TFAM1 to 9) promoter was analyzed by real-time
RT-PCR. Binding intensity data were normalized to ActB (nonspecific binding)
and are presented as the mean ± SEM for at least three independent experi-
ments. * denotes p < 0.05.Ce7B). During glucose stimulation, mitochondrial calcium enters
through the calcium uniporter, while extrusion of the ion occurs
mainly via the mitochondrial Na+/Ca2+ exchanger (mNCE). The
benzothiazepine CGP37157 blocks mNCE, amplifies the action
of glucose on mitochondrial Ca2+, and increases GSIS (Lee
et al., 2003). Acute addition of CGP37157 to Pdx1-deficient islets
restored the effect of glucose on mitochondrial Ca2+ (Figure 7A,
right panel, and Figure 7B). This rise in calcium should accelerate
oxidative metabolism and promote ATP synthesis. Consistent
with this premise, addition of CGP37157 to DN79PDX1-express-
ing islets resulted in complete normalization of glucose-induced
ATP generation (Figure 7C). In parallel, the attenuated GSIS
observed in islets transduced with RIPDN79PDX1 was restored
(Figure 7D). At the low CGP37157 concentration (0.1 mM) applied,
the compound did not affect mitochondrial calcium or cytosolic
ATP responses nor did it enhance insulin secretion from control
islets.
DISCUSSION
The main finding of this study is the unexpected transcriptional
control of the ubiquitously expressed nuclear-encoded mito-
chondrial transcription factor TFAM by Pdx1 in the b cell.
Pax4, another b cell-enriched transcription factor, controls the
widely expressed genes c-myc and bcl-xl (Brun et al., 2004). In
this manner, b cell function and survival is ensured through the
appropriation of nonselective cellular regulators. We demon-
strate that acute suppression of Pdx1 in adult mice downregu-
lates TFAM, which, based on our results, should contribute to
impaired insulin secretion and hyperglycemia in these animals
(Holland et al., 2002, 2005). In contrast, TFAM mRNA was not
significantly reduced when Pdx1 transcript levels were only
modestly decreased, by 23%, in Pdx1+/ mouse islets (Brissova
et al., 2002). This discrepancy may be related to a gene dosage
effect of Pdx1 depletion. In good agreement with the results
obtained in acutely Pdx1-depleted mice, rat islets transduced
with a dominant-negative variant of Pdx1 (DN79PDX1) displayed
a 50%–60% reduction in TFAM mRNA levels (Gauthier et al.,
2004).
We have demonstrated direct binding of Pdx1 to the human
and the rat tfam gene promoter. Moreover, Pdx1 induced tran-
scriptional activation of the rat promoter. These results make it
unlikely that DN79PDX1 effects TFAM expression in a nonspe-
cific manner. The latter is substantiated by the maintained
expression of other homeodomain transcription factor targets,
such as the Pax4-regulated bcl-xl gene (Brun et al., 2004; Gauth-
ier et al., 2004). Expression of this gene is also normal in another
Pdx1 heterozygous mouse model (Johnson et al., 2003). Inter-
estingly, several Pdx1 binding sites were revealed up to 3 kb
upstream of the transcriptional start site in the human promoter,
whereas only a single site was found in the rat gene. It appears
that the basal transcriptional control of TFAM is exerted through
the binding of NRF1, NRF2, and SP1 as well as hStaf/ZNF143 to
the proximal promoter region (Ge´rard et al., 2007; Scarpulla,
2008), while Pdx1 binding further upstream may confer b cell-
autonomous regulation.
Our earlier work suggested that 56 transcripts were downre-
gulated in Pdx1-deficient rat islets, including the mtDNA-
encoded polypeptides of the respiratory chain, such as thell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Inc. 113
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TFAM and Defective Insulin SecretionNd1 subunit of complex I (Gauthier et al., 2004). TFAM overex-
pression practically normalized Nd1 mRNA levels. In contrast,
the adaptive elevated transcript of the nuclear-encoded succi-
nate dehydrogenase remained high, perhaps explained by the
relatively short islet culture period (48 hr). TFAM is known not
only to control mtDNA transcription but also to stabilize the mito-
chondrial genome by substituting histone function (Ekstrand
et al., 2004; Scarpulla, 2008). Indeed, we found that the
decreased nd1 gene copy number in DN79PDX1 islets was
restored after TFAM overexpression. Remarkably, the sole over-
expression of TFAM in islets with deficient Pdx1 function
completely restored glucose-induced ATP generation as well
as insulin secretion. These results establish TFAM regulation
as the causal link between loss of Pdx1 function and defective
respiratory chain activity.
b cell-specific ablation of TFAM results in defective insulin
secretion and time-dependent loss of b cell mass (Silva et al.,
2000). Similarly, Pdx1+/ mice develop hyperglycemia and
age-dependent b cell apoptosis in vivo, correlating with
increased susceptibility to cell death in vitro (Johnson et al.,
2003). Such susceptibility was also inferred from the gene profile
of DN79PDX1 islets with increased caspase-3 and decreased
Bcl-2 mRNA levels (Gauthier et al., 2004). It is of interest, in
this context, that TFAM transcript levels in rat insulinoma
INS-1E cells are 4 times higher than those of rat islets and liver
(B.R.G. and C.B.W., unpublished data). This may contribute to
the resistance of INS-1E cells to palmitate-induced apoptosis
compared to primary b cells (Lai et al., 2008). Along the same
line, TFAM overexpression has been reported to protect cardio-
Figure 4. Adenoviral-Mediated Overexpression of TFAM
in DN79PDX1-Expressing Rat Islets Partially Restores
NADH DH ND1 Transcript Levels
(A and B) Rat islets were transduced with either 4 or 173 105 viral
particles/islet of AdrTFAM and cultured for 48 hr. RNA as well as
cytosolic and mitochondrial protein fractions were subsequently
isolated, and levels of TFAM transcript (A) and protein (B) were
estimated by real-time RT-PCR and western blotting, respectively.
(C) Expression levels of NADH DH ND1 and succinate dehydroge-
nase (SUC DH) were evaluated by real-time RT-PCR in islets
infected with the indicated adenoviral constructs. Values were
normalized to the housekeeping gene cyclophilin and compared
to islets infected with AdCaLacZ. Data are the means ± SEM of
four independent experiments performed in triplicate. * denotes
p < 0.05.
Figure 5. Mitochondrial DNA Copy Number Is Decreased in Islets
Expressing DN79PDX1 and Is Restored by TFAM
Rat islets were transduced with the indicated adenoviruses (43 105 viral parti-
cles/islet), and genomic DNA (nuclear and mitochondrial) was isolated 48 hr
postinfection. Real-time PCR was then performed in order to evaluate gene
copy number of NADH DH ND1 (mitochondrial) and SUC DH (nuclear). Values
were normalized to the housekeeping gene cyclophilin and compared to islets
infected with AdCaLacZ. Data are the means ± SEM of three independent
experiments performed in triplicate. * denotes p < 0.01.
myocytes from glucose-induced oxidative stress by
increasing mtDNA copy number and preserving respi-
ratory chain function (Suarez et al., 2008). Similarly,
TFAM transgenic mice are protected from age-depen-
dent memory impairment and mitochondrial DNA
damage in brain microglia (Hayashi et al., 2008). Of
note, a TFAM genetic variant has been associated
with Alzheimer’s disease in several populations (Belin
et al., 2007; Bertram et al., 2007). The published
results, together with our findings, strongly implicate
TFAM in the preservation of mitochondrial function.
This conclusion is substantiated by the acute resto-
ration by CGP37157 of mitochondrial calcium eleva-
tion and ATP generation in glucose-stimulated Pdx1-
deficient islets. It is of particular interest that glucose-induced
insulin secretion was completely normalized by this inhibitor of
the mNCE, demonstrating that the rise in mitochondrial calcium114 Cell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Inc.
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TFAM and Defective Insulin Secretioncan compensate for reduced levels of mtDNA-encoded respira-
tory chain complex subunits. CGP37157 was previously shown
to enhance GSIS (Lee et al., 2003) as well as hyperpolarizing
the mitochondrial membrane potential and generating NAD(P)H
(Luciani et al., 2007). Despite evidence of mitochondrial activa-
tion in the latter study, Luciani et al. reported dose-dependent
inhibition of voltage-gated Ca2+ influx in mouse islet b cells. At
0.1 mM CGP37157, GSIS but not calcium signaling was inhibited.
This contrasts markedly with the unaltered GSIS in control islets
exposed to CGP37157 observed in the present study. Whatever
the reason for this discrepancy on insulin secretion, under condi-
tions of limited mitochondrial function, CGP37157 appears to
facilitate glucose action in the b cell by restoring the mitochon-
drial calcium signaling and ATP synthesis. A similar beneficial
effect of CGP37157 on ATP synthesis and hormone-mediated
calcium signaling was reported in skin fibroblasts from patients
with isolated mitochondrial complex I mutations (Visch et al.,
2004). Likewise, a mutation in the mtDNA-encoded tRNALys
causes a global impairment of mitochondrial protein synthesis,
resulting in deficits in both respiratory chain function and in
oxidative phosphorylation, manifested as myoclonic epilepsy.
In cells expressing this mutation, treatment with CGP37157
dramatically restored not only the calcium signal but also ATP
generation (Brini et al., 1999).
Pdx1 is undisputed as the crucial transcription factor required
for pancreas development and maintenance of differentiated
b cell function, in particular normal glucose regulation of insulin
secretion. The present work establishes a direct link between
Pdx1 transcriptional activity and mitochondrial signal generation
Figure 6. Overexpression of TFAM in DN79PDX1-Infected
Islets Restores Both Glucose-Induced ATP Production
and Insulin Secretion
(A) Rat islets were infected with the indicated adenoviruses (4 3
105 viral particles/islet) along with the adenoviral construct encod-
ing the ATP-sensitive bioluminescence probe luciferase and
cultured for 48 hr. Cytosolic ATP production in response to
16.5 mM glucose was then determined over a period of 25 min
(shown in A). Luminescence was recorded in a FLUOstar Optima
apparatus. Islets were equilibrated in KRBH buffer for 30 min prior
to initiation of recording. Glucose (stripped bar) and azide (gray
bar) were added at indicated times. Results are the mean ± SEM
of at least four experiments performed in duplicates.
(B) Insulin secretion was assessed in 30 min static incubations in
response to 2.5 mM (white bars) or 16.5 mM glucose (black
bars). Insulin released in KRBH was quantified by Enzyme Immu-
noassay (EIA) and expressed as a percentage of total cellular
insulin content. Results are the mean ± SEM from four indepen-
dent experiments performed in duplicates. **p < 0.01.
in the moment-to-moment control of insulin release.
The latter is achieved through the product of the
nuclear gene tfam that ensures mitochondrial DNA
stability and transcription. TFAM downregulation as
a consequence of Pdx1 deficiency can be overcome
either by genetic restoration of TFAM expression or
by pharmacological enhancement of mitochondrial
calcium signaling. Both of these approaches normalize
GSIS caused by Pdx1 loss of function. In view of our
results, screening of TFAM genetic variants might
be warranted in type 2 diabetic patients with impaired insulin
secretion.
EXPERIMENTAL PROCEDURES
Rats and Transgenic Mice
Seven-week-old male Wistar rats (250 g) were purchased from Elevage Janv-
ier (Le Genest-Saint-Isle, France). Pdx1tTA/tTA; TgPdx1 transgenic mice bearing
a conditionally DOX-repressed pdx1 transgene were obtained from Dr. Ray-
mond MacDonald (University of Texas Southwestern Medical Center; Dallas,
TX). A detailed description on the generation of these mice is provided in the
References (Holland et al., 2002, 2005). DOX was initially administered to
6-month-old males by a single i.p. injection (100 mg/kg in final volume of
250 ml of water) and was subsequently maintained in the drinking water (1 g
DOX/l) for 14 consecutive days. Glycemia was monitored daily using a Preci-
sion Xceed apparatus (Abbott AG; Baar, Switzerland). Hyperglycemic animals
were sacrificed, and pancreas was extracted for islet isolation.
Islet Isolation and Cell Culture
Pancreatic islets were isolated by collagenase digestion, handpicked, and
maintained in 11.1 mM glucose/RPMI-1640 (Invitrogen; Basel) supplemented
with 10% FCS (Brunschwig AG; Basel), 100 U/ml penicillin, and 100 mg/ml
streptomycin (Sigma; Basel) (Ishihara et al., 1999). INS-1 cells conditionally
expressing Pdx1 (Wang et al., 2001) were cultured in RPMI-1640 (Invitrogen)
supplemented with 10% FCS (Brunschwig AG) and other additions as
described previously (Asfari et al., 1992). Pdx1 expression was induced by
the addition of DOX to the media.
Recombinant Adenoviral Construction and Islet Transduction
The rat TFAM (rTFAM) cDNA was amplified from poly(A) RNA isolated from
liver. The 730 bp amplicon generated using oligonucleotides spanning the
START codon (50-CGC TAG CAT GGC GCT GTT CCG GGG AAT G-30;
NheI site shown in italic and START codon underlined) and STOP codonCell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Inc. 115
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TFAM and Defective Insulin SecretionFigure 7. CGP37157 Restores the Defective Mito-
chondrial Calcium Response, ATP Production,
and Insulin Secretion of Rat Islets Expressing
DN79PDX1
(A) Rat islets were coinfected with the adenovirus
rAdCAGmitoAequorin for the measurement of mito-
chondrial calcium and either AdLacZ (control) or
AdRIPDN79PDX1 adenovirus. Left panel: Expression of
DN79PDX1 (gray trace) reduces the mitochondrial calcium
response to glucose when compared to control islets
infected with AdlacZ virus (black trace). Right panel:
Comparison of the mitochondrial calcium response to
glucose of islets expressing DN79PDX1 in the presence
(black trace) and absence (gray trace) of 0.1 mM
CGP37157. CGP37157 was added 2 min prior to glucose
as indicated.
(B) During the 5 min following initiation of the glucose
response, the mitochondrial calcium concentration above
basal was integrated and expressed as the percent of the
AdLacZ-infected control islets.
(C) Isolated rat islets were infected with the indicated
adenoviruses (4 3 105 viral particles/islet) along with the
adenoviral construct encoding the ATP-sensitive biolumi-
nescence probe luciferase and cultured for 48 hr.
CGP37157 (0.1 mM) was added just prior to ATP measure-
ment. Cytosolic ATP production in response to 16.5 mM
glucose was evaluated over a period of 25 min. Islets
were equilibrated in KRBH buffer for 30 min, and lumines-
cence was subsequently recorded in a FLUOstar Optima
apparatus. Glucose (striped bar) and azide (gray bar)
were added at indicated times. Results are the mean ±
SEM of at least four experiments performed in duplicates.
(D) Insulin secretion was assessed in 30 min static incuba-
tions in response to 2.5 mM or 16.5 mM glucose in the
presence or absence of 0.1 mM CGP37157. Insulin
released in KRBH was quantified by EIA and expressed
as a percentage of total cellular insulin content. Results
are the mean ± SEM from four independent experiments
performed in duplicates. **p < 0.01.(50-CTC TAG ATT AAT TCT CAG AGA TGT C-30; XbaI site shown in italic and
STOP codon underlined) was cloned into the pGEM-T Easy Vector (Promega
Corporation; Madison, WI). Positive clones were sequenced to confirm integ-
rity of the coding region. The rTFAM cDNA was then excised using the restric-
tion enzymes NheI and XbaI, gel purified, and subcloned into the NheI/XbaI
sites of the pCMV/DLDU6 vector. The latter vector was derived from pDLDU6
(Brun et al., 2007) by cloning the CMV promoter DNA fragment into the MluI/
PmeI sites. The CMV/TFAM cassette was subsequently transferred into the
Adeno-X viral DNA, and recombinant adenoviruses (AdrTFAM) were produced
according to the manufacturer’s recommendations (Clontech; Mountain View,
CA). The recombinant adenovirus AdRIPDN79PDX1, harboring the rat insulin 1
promoter and coding sequence of DN79PDX1, was previously described
(Gauthier et al., 2004). AdCaLacZ, containing the bacterial b-galactosidase
cDNA, was used as a control adenovirus (Ishihara et al., 1999). Eighteen hours
postisolation, islets were infected with various amounts of recombinant
adenoviruses (AdCaLacZ, 4 3 105 viral particles/islet; AdRIPDN79PDX1, 4 3
105 viral particles/islet; and AdrTFAM, 4 and 17 3 105 viral particles/islet) for
90 min, washed, and cultured in RPMI medium for an additional 48 hr.
Real-Time RT-PCR
Total RNA was extracted using the QIAGEN RNeasy Mini Kit, and 1 mg was
converted into cDNA as previously described (Gauthier et al., 1999). Genomic
DNA was isolated from rat islets using the QIAGEN DNeasy Mini Kit. Primers
were designed using the Primer Express Software (Applera Europe; Rotkreuz,
Switzerland), and sequences can be obtained upon request. The same primers116 Cell Metabolism 10, 110–118, August 6, 2009 ª2009 Elsevier Infor succinate dehydrogenase, NADH ND1, and cyclophilin were used to
amplify genomic DNA and cDNA.
Real-time PCR was performed using an ABI 7000 Sequence Detection
System (Applera Europe), and PCR products were quantified fluorometrically
using the SYBR Green Core Reagent Kit. Three distinct amplifications were
performed in duplicates for each transcript, and mean values were normalized
to the mean value of the reference mRNA cyclophilin.
Immunoblot Analysis
Mitochondrial and cytosolic protein extract fractions (10 and 20 mg) isolated
from either AdLacZ or AdrTFAM-infected islets were resolved on a 10%
SDS-polyacrylamide gel and transferred electrophoretically to a PVDF
membrane. The membrane was blocked with 3% Topblock and 0.4% Tween
20 in PBS for 1 hr and then left overnight at 4C in the presence of a rabbit
TFAM antibody (kindly provided by Dr. N.G. Larsson, Karolinska Institute;
Stockholm, Sweden) at a 1:5000 dilution. A goat anti-rabbit IgG antiserum
conjugated to horseradish peroxidase (1:4000) (GE Healthcare; Otelfingen
Switzerland) was then added for 60 min, and immunoreactive products were
visualized by enhanced chemiluminescence (SuperSignal West Pico, Pierce;
Rockford, IL) followed by exposure to X-Omat Kodak films (Eastman Kodak
Co.; Rochester, NY) for less than 1 min.
Electromobility Shift Assay (EMSA)
Nonradioactive EMSA was performed using the LightShift Chemiluminescent
Kit (Pierce). Briefly, 6 mg of nuclear extracts purified from noninduced andc.
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either a double-stranded biotinylated INSFLAT element of the rat insulin
promoter (50-CCG ATC TTG TTA ATA ATC TAA TTA CC-30) or with the putative
Pdx1 binding site of the rTFAM promoter (50-CCA AAG ATT AGA TAA ACA AAG
CGA TAC ATT T-30). Subsequent to electrophoresis, the gel was blotted onto
a PVDF membrane, and DNA/protein complexes were revealed using a strepta-
vidin-horseradish peroxidase conjugate as outlined by the manufacturer.
ChIP Assay
ChIP assays were performed as described by Pa´rrizas et al. (2003). Briefly,
formaldehyde-crosslinked chromatin extracts were prepared from either
INS-1 cells conditionally expressing Pdx1 (rab-Pdx1-21; 4 3 106 cells/condi-
tion) (Wang et al., 2001) or from human islets (1000–2000 islets/condition)
and fragmented by sonication. Chromatin extracts (10 mg) were first precleared
with protein G Sepharose beads (GE Healthcare; Uppsala) for 1 hr. After centri-
fugation (10 g for 2 min at 4C), 10% of each supernatant was kept as input,
while the remaining samples were incubated overnight at 4C with a goat
anti-Pdx1 serum (1:500 dilution for human samples and 1:200 for INS-1E
samples) kindly provided by Dr. Christopher Wright (Vanderbilt University;
Nashville, TN). A rabbit IgG (#sc-2027; Santa Cruz Biotechnology; Santa
Cruz, CA) was also used as negative control. DNA/protein/antibody complexes
were then incubated for 2 hr with protein G Sepharose beads and subsequently
washed sequentially in a low-salt buffer, high-salt buffer, LiCl buffer, and finally
Tris/EDTA buffer. DNA/protein complexes were then eluted from the beads
using a solution containing 1% SDS and 0.1 M NaHCO3. Proteins were elimi-
nated using 400 mg of Proteinase K (QIAGEN) by incubation at 45C for 2 hr.
DNA samples were then purified using the QIAGEN DNeasy Blood and Tissue
Kit. The PCR primers used for analysis of Pdx1 binding to the human and rat
tfam gene promoters can be obtained upon request. PCR products were veri-
fied on 2% ethidium bromide-stained agarose gels and/or analyzed by real-
time PCR using an ABI 7000 Sequence Detection System (Applera Europe).
Transient Transfection Assays
The proximal rat tfam gene promoter was amplified from genomic DNA iso-
lated from pancreatic islets using the following primers: rTFAM-PROM-50,
50-AAA GAT TAG ATA AAC AAA GC-30; and rTFAM-PROM-30, 50-CAG GGG
CTT GTT ATC ATG CC-30. The amplicon was cloned into the pGEM-T Easy
Vector (Promega) and sequenced to confirm integrity of the 50-flanking region.
The tfam gene promoter fragment was then excised using the restriction
enzyme EcoRI, made blunt-ended using the Klenow fragment of the DNA
polymerase I, gel purified, and subcloned into the SmaI restriction site of the
pGL3-Basic luciferase reporter vector (pTFAM/LUC) (Promega). The BHK-21
cell line was transiently transfected using the calcium phosphate precipitation
technique as described previously (Gauthier et al., 2002). Three micrograms of
pTFAM/LUC were cotransfected with increasing amounts of a Pdx1 expres-
sion vector (0.125, 0.25, 0.5, and 1 mg). The pSV-b-galactosidase vector
(1 mg) (Promega) was used as internal control to normalize for transfection effi-
ciency (approximately 15%) in all experiments. Values correspond to the mean
and SEM of at least 4–5 individual transfections performed in duplicate.
Results are presented as fold induction of the control sample obtained from
cells transfected with empty expression vector.
Insulin Secretion Assay and ATP Measurement
Islets were washed in Krebs-Ringer-bicarbonate-HEPES buffer (KRBH)
(140 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 0.5 mM MgSO4, 1.5 mM
CaCl2, 2 mM NaHCO3, 10 mM HEPES, 0.1% BSA) and incubated at 37
C
for 60 min in the same buffer supplemented with 2.5 mM glucose. Subse-
quently, insulin secretion from 15 size-matched islets per condition was
measured over a period of 30 min in KRBH containing the indicated stimula-
tors. In some instances, 0.1 mM CGP37157 was added to the reaction. Total
insulin content was extracted using acid ethanol. Insulin was detected using
the Rat Insulin Enzyme Immunoassay Kit as described by the manufacturer
(SPI-BIO/Bertin Pharma Biotech Division; Brunschwig AG). Secreted insulin
was expressed as percentage of total cellular insulin content.
Alterations in cytosolic ATP levels in response to 16.5 mM glucose or 0.1 mM
CGP37157/16.5 mM glucose were monitored using the adenoviral construct
AdCAGLuc encoding the ATP-sensitive bioluminescence probe luciferase
(Ishihara et al., 2003). Islets were preincubated at 37C for 30 min in KRBHCebefore the addition of 2.5 mM glucose and 500 mM beetle luciferin (Promega).
Changes in ATP were then recorded using a FLUOstar Optima apparatus
(BMG Labtech; Jena, Germany) as previously described by Merglen et al.
(2004).
Mitochondrial Calcium Measurements
Mitochondrial calcium signals were measured using an adenovirus expressing
mitochondrially targeted aequorin as described previously (Brun et al., 2004).
Rat islets were coinfected with AdCAGmitoAequorin (4 3 107 pfu/ml) along
with either a control AdLacZ virus or the AdRIPDN79PDX1. After infection,
islets were washed and seeded onto A431 matrix-coated coverslips. Two
days after infection, the islets were analyzed as previously described (Brun
et al., 2004). Where indicated, 0.1 mM CGP37157 was added prior to glucose
stimulation.
Statistical Analysis
Results are expressed as mean ± SEM. Where indicated, the statistical signif-
icance of the differences between groups was estimated by Student’s t test.
* and ** indicate statistical significance with p < 0.05 and p < 0.01, respectively.
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